Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June
A catalog of curated breast cancer genes
William Oh on LinkedIn: Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for…
Breast cancer risk estimates from composite gene model in validation
Frontiers Implementation of multigene panel testing for breast and ovarian cancer in South Africa: A step towards excellence in oncology for the public sector
FDA Authorizes First Genetic Test to Assess Risk of Multiple Cancers
A Population-Based Study of Genes Previously Implicated in Breast Cancer
CHEK2 Carrier Modification with Polygenic Risk Score
PALB2 – Inherited Cancer Registry (ICARE)
BREAST CANCER PRS (Polygenic Risk Score) –
Interpreting Cancer Genetic Testing Results (CME)
/books/NBK65767/bin/CDR0000766